An observational study of post prandial hypertriglyceridemia is a reliable predictor for coronary artery disease
Keywords:
hypertriglyceridemia, myocardial infarction, coronary artery disease, atherosclerosisAbstract
Introduction: Hypertriglyceridemia is recognized as a high-risk factor for coronary artery disease. It remains unclear whether fasting or postprandial hypertriglyceridemia is more informative for predicting the risk of coronary artery disease. Recent studies recommended postprandial Hypertriglyceridemia as a useful predictor of cardiovascular disease risk. This study was conducted to find the correlation between postprandial Hypertriglyceridemia in patients with coronary artery disease. Materials and Methods: This was an observational study on 100 patients diagnosed with coronary artery disease from 14/10/2017 to 10/09/2018. In patients diagnosed with coronary artery disease based on ECG changes or TMT, changes were included in the study. Fasting lipid profile, FBS, and 2-hour postprandial Triglyceride were done. All statistical data were analyzed using frequency, percentages, and ratios. A chi-square test is used to study the associations among different variables. Results: Among the 100 cases included in the study, 68 were males, and 32 were females. Postprandial Hypertriglyceridemia was found in 71% of patients, 48% had high BMI, 80% of Patients had high Waist Hip ratio, and 64 % of patients had diabetes mellitus. There is a statistically significant correlation between postprandial Triglyceride and coronary artery disease with a relative risk of 1.45.Downloads
References
Austin MA. Plasma triglyceride and coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 1991; 11(1): 2 -14 .
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. J Am Med Assoc.2007;298(3):309–16.
Carlson LA, Böttiger LE. Risk factors for myocardial infarc-tion in the Stockholm Prospective Study. Acta Medica Scan-dinavica. 1979; 206(1‐6): 351-60.
Couillard C, Bergeron N, Prud’Homme D, Bergeron J, Tremblay A, Bouchard C, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes. 1998;47(6):953–60.
Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson JL. harrison’s principles of internal medicine. 19th Editi. McGraw-Hill Education; 2017. 0–3985p.
Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858
Kolovou GD, Daskalova DC, Adamopoulou EN, Pilatis ND, Hatzigeorgiou GC, Cokkinos D V., et al. Postprandial Lipemia in Hypertension. J Am Coll Nutr. 2003;22(1):80–7.
Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and car-diovascular disease a scientific statement from the American Heart Association. Circulation. 2011; 123(20): 2292-2333.
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. J Am Med Assoc.2007;298(3):299–308.
Patel A. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation.2004;110(17):2678–86.
Ratnawati, I. G. A. A., Suandayani, N. K. T., & Sutapa, G. N. (2019). The linearity of x-ray devices radiation output and its relationship with patient thickness. International Journal of Physical Sciences and Engineering, 3(3), 1–6. https://doi.org/10.29332/ijpse.v3n3.351
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Tirosh A, Rudich A, Shochat T, et al. Changes in triglyceride lev-els and risk for coronary heart disease in young men. Annals of Internal Medicine. 2007; 147(6): 377-85.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
